Atlas Trials

Myelogenous Leukemia, Acute

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myelogenous Leukemia, Acute

RecordFirmDate
Bisantrene Combination for Resistant AML (NCT04989335)Sheba Medical Center2021-08-02
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia (NCT02665065)Actinium Pharmaceuticals2016-06-01
A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (NCT01773408)Hoffmann-La Roche2013-02-01
A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia (NCT01641250)Hoffmann-La Roche2012-08-01
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia (NCT01635296)Hoffmann-La Roche2012-07-01
Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) (NCT00907517)Merck Sharp & Dohme LLC2009-07-29
MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease (NCT00374296)Mirati Therapeutics Inc.2006-09-01
Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (NCT00130702)Dana-Farber Cancer Institute2005-08-01

Track Myelogenous Leukemia, Acute automatically

Every clearance here is in the API, with alerts when new ones post.